|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
1 months to Dec 31, 2020
|
|
|---|---|---|---|
| Cash Flows from Operating Activities | |||
| Net Income | |||
| Accrued expenses | |||
| Adjustments to reconcile net income to cash used in operating activities: | |||
| Change in fair value of derivative warrant liabilities | |||
| Accretion of discount, net on marketable securities | |||
| Accounts payable and accrued expenses | |||
| Income taxes payable | |||
| Cash used in operating activities | |||
| Cash Flows from Investing Activities | |||
| Acquisition of marketable securities | |||
| Proceeds from sale of marketable securities | |||
| Cash provided by (used in) investing activities | |||
| Cash Flows from Financing Activities | |||
| Proceeds from sale of Public Units | |||
| Proceeds from sale of Private Placement Warrants | |||
| Proceeds from primisorry note - related party | |||
| Repayment of promissory note - related party | |||
| Payment of offering costs | |||
| Payment for redemptions of Class A Common Stock | |||
| Cash provided by (used in) financing activities | |||
| Change in Cash | |||
| Cash – Beginning of period | |||
| Cash – Ending of period | |||
| Deferred offering costs included in accrued offering costs | |||
| Payment of deferred offering costs paid by Sponsor in exchange for the issuance of Class B common stock | |||
| Cash - Beginning of period | |||
| Cash - End of period | |||
| Cash | |||
| Cash in Trust Account | |||
| Supplemental Disclosure of Non-cash Financing Activities | |||
| Deferred underwriting fee |
Loading...
